STMM
TEVA icon

South Texas Money Management’s Teva Pharmaceuticals TEVA Stock Holding History

South Texas Money Management’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-42,332
Closed -$745K – 218
2017
Q3 		$745K Sell
42,332
-8,486
-17% -$191K 0.04% 121
2017
Q2 		$1.69M Sell
50,818
-658,874
-93% -$20.4M 0.08% 84
2017
Q1 		$22.8M Buy
709,692
+283,123
+66% +$9.66M 1.14% 38
2016
Q4 		$15.5M Buy
+426,569
New +$17M 0.81% 49
2016
Q1 		– Sell
-3,587
Closed -$235K – 224
2015
Q4 		$235K Buy
+3,587
New +$222K 0.01% 184

Other funds holding TEVA

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
HCM
Highfields Capital Management Boston, Massachusetts $68.3M AUM 21.64% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NC
Northern Cross Boston, Massachusetts $279M AUM 1.98% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
Berkshire Hathaway
Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return
BC
Brahman Capital New York $275M AUM 18.08% 1-Year Est. Return

South Texas Money Management's TEVA Position: Q4 2017 in Review

South Texas Money Management sold out of Teva Pharmaceuticals (TEVA) in Q4 2017, closing a stake of 42,332 shares — an estimated $745K sold.

South Texas Money Management first reported a position in TEVA in Q4 2015 and held it in 5 quarters. The position peaked at $22.8M in Q1 2017. 508 funds tracked by Wall St. Rank hold TEVA as of Q4 2017.

  • South Texas Money Management reported no remaining Teva Pharmaceuticals position as of Q4 2017 after selling out during the quarter.
  • South Texas Money Management sold 42,332 Teva Pharmaceuticals shares in Q4 2017, an estimated $745K.
  • South Texas Money Management first reported a position in Teva Pharmaceuticals in Q4 2015 and held it in 5 quarters.
  • South Texas Money Management's Teva Pharmaceuticals position peaked at $22.8M in Q1 2017.
  • 508 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q4 2017.

Based on South Texas Money Management's 13F filing for Q4 2017, filed 7 Feb 2018.